Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma

Oncology Reports
Kai JiangYinkun Liu

Abstract

Golgi protein 73 (GP73), a resident Golgi type-II membrane protein, is often upregulated in hepatocytes. In the present study, shRNA-mediated suppression of GP73 expression in hepatocellular carcinoma (HCC) cell lines (MHCC97H, HCCLM3) resulted in a significant inhibition of cell motility and invasion and also led to the regression of epithelial-mesenchymal transition phenotypes. In contrast, overexpression of GP73 in the SMMC7721 cell line retrieved the expression of EMT markers, and promoted cell motility and invasion. High expression of GP73 was also found in HCC tissues with metastasis, as detected by western blot and immunohistochemistry analyses. Kaplan-Meier survival analysis showed that the survival of patients with high GP73 expression was significantly poorer than that of patients with low GP73 expression (p=0.027). Our findings demonstrated an important role of GP73 in HCC metastasis, and indicated that GP73 is a candidate target for HCC therapy.

References

Jan 25, 2002·Molecular Carcinogenesis·Jian-Hua LuoMichael Becich
May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raleigh D KladneyClaus J Fimmel
Aug 22, 2002·Nature Reviews. Cancer·Jean Paul Thiery
Jun 19, 2003·Molecular & Cellular Proteomics : MCP·Anne-Sofie SchrohlUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Receptor and Biomarker Group
Jun 8, 2004·The American Journal of Gastroenterology·Rehan IftikharClaus J Fimmel
Jan 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Timothy M BlockAnand S Mehta
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 3, 2005·Journal of Hepatology·Jorge A MarreroTimothy M Block
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Jean Paul Thiery, Jonathan P Sleeman
Jun 20, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G Giannelli, S Antonaci
Nov 19, 2008·BMC Urology·Florian Rudolf FritzscheGlen Kristiansen
Mar 6, 2009·Nature Reviews. Cancer·Kornelia Polyak, Robert A Weinberg
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc-Oliver RienerGlen Kristiansen
Jul 15, 2009·Journal of Hepatology·Lorinda M WrightClaus J Fimmel
May 27, 2010·Clinical Biochemistry·Fangfang ZhangTao Peng
Dec 9, 2010·International Journal of Cancer. Journal International Du Cancer·Liyuan TianYaping Tian
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 30, 2011·Journal of Gastroenterology and Hepatology·Yongliang SunHongbing Zhang
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Jan 25, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wen WenHongyang Wang
Sep 27, 2012·The International Journal of Biochemistry & Cell Biology·Cun WangYinkun Liu
Mar 12, 2013·The International Journal of Biochemistry & Cell Biology·Chun SunYin-Kun Liu
Jun 19, 2013·Cancer Research·Bing CuiThomas J Kipps
Jul 11, 2013·Annals of Surgical Oncology·Ming-Huang ChenGar-Yang Chau

❮ Previous
Next ❯

Citations

Sep 22, 2018·The International Journal of Biological Markers·Yunsheng ZhaoLiang Jin
Oct 21, 2018·Cell Proliferation·Yanyan XiaNongyue He
Oct 3, 2017·The International Journal of Biological Markers·Yunsheng ZhaoFei Liao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.